about
Affordability of medicines in the European UnionCosts of treatment of adult patients with cystic fibrosis in Poland and internationally.Compliance Among Adolescents with Arterial Hypertension.Feasibility of Atrial Fibrillation Screening With Mobile Health Technologies at PharmaciesAnalysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland)Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting processEconomic and clinical evaluation of vagus nerve stimulation therapy
P50
Q36291455-3AA8D04C-9C87-45B7-8E0C-225DA119D2EBQ38731036-74C0EA19-FB40-4DDC-A44E-B01BEB95A4E8Q39389067-AB941E9B-29A8-4233-A114-8FA0E2C4236AQ90439246-3FA3AF32-AF06-4B30-B3B5-00717B334940Q91265268-0C44E70A-F726-4F7E-A15E-1BD19E8511BBQ92425743-4741211F-EAE2-4A04-844D-5BCACE925DA6Q92530368-04AD6516-86A5-4273-8FD5-4B386C96B9E0
P50
description
researcher
@en
name
Dorota Kopciuch
@en
type
label
Dorota Kopciuch
@en
prefLabel
Dorota Kopciuch
@en
P31
P496
0000-0001-6547-6112